Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India

Published:2019-10 Issue:5 Volume:43 Page:391-401
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Singh Varsha,Guleria Prerna^ORCID,Malik Prabhat Singh,Mohan Anant,Thulkar Sanjay,Pandey R M,Luthra Kalpana,Arava Sudheer,Ray Ruma,Jain Deepali

Funder

Lady Tata Memorial Trust

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy;Santarpia;Expert Opin Ther Targets,2012

2. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer;Roberts;Oncogene,2007

3. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches;De Luca;Expert Opin Ther Targets,2012

4. MAP kinase signalling pathways in cancer;Dhillon;Oncogene,2007

5. Signaling through the epidermal growth factor receptor during the development of malignancy;Grandis;Pharmacol Ther,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023);Molecular Diversity;2024-07-20

2. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients;Clinical Lung Cancer;2024-07

3. KRAS and BRAF genetic alterations in lung cancer: A case − control study;Journal of Cancer Research and Therapeutics;2024-04

4. Epidemiology of EGFR Mutation in Adenocarcinoma NSCLC Patients in India: A Systematic Review and Meta-Analysis;Advances in Lung Cancer;2024

5. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-Small Cell Lung Cancer Patients;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3